Sharon L. Mulvagh MD, FRCP(C), FASE, FACC, FAHA
Organizing Committee
Sharon L. Mulvagh (Chair), Igal Sebag (Co-Chair), Chi-Ming Chow (Webmaster),
Jeremy Adams, Shaheeda Ahmed, Aws Almufleh, Carly Burry, Ian Burwash,
Annabel Chen-Tournoux, Michael Chetrit, Heather Cooley, Robin Ducas, Tyler Lamb, Christina Luong, David Messika-Zeitoun, Thi Kim Hanh Nguyen, Steven Promislow, Kenneth Szeto, Sara Faubert
If you encounter any errors during the registration process, please email Helpdesk@sw-online.com
Overall Course Objectives:
At the end of this program, participants will be able to:
-Describe the current role and application of echocardiography in patients with suspected and overt cardiac disease
- Identify how novel and evolving echocardiography techniques can be applied to the clinical practice of echocardiography
-Describe how echocardiography integrates with other cardiac imaging modalities to optimally evaluate the patient with suspected or confirmed cardiovascular disease
Overall and individual session goals will be obtained by offering expert speakers combined with an interactive and usually case-based format to enhance applicability of transmitted information.
Adequate time will be reserved for audience questions, comprising approximately 25% of each talk/session.
In addition, faculty will be available for audience questions during breaks. In order to optimize audience concentration, presentations will be available to the registrants in a PDF format prior to the live presentations.
Session Objectives
The Conundrum of the Thick Heart: A Multimodality Imaging Approach
At the end of this session, the participant will be able to:
-Review the role of echocardiography and multimodality imaging in diagnosis and management of hypertrophic cardiomyopathy
-Understand the indications for and interpretation of echocardiography and multimodality imaging in diagnosis and management of infiltrative cardiomyopathies.
-Recognize the continued and evolving utility of echocardiography and complementary imaging modalities in evaluation of the thickened myocardium through case-study analysis.
Pericardial Disease: Navigating the Spectrum
At the end of this session, the participant will be able to:
-Discuss the echocardiographic diagnosis of pericardial tamponade.
-Describe the echocardiographic manifestations of constrictive pericarditis
-Understand the importance of echocardiography as well as multi-modality imaging to guide diagnosis and management of pericarditis.
Adult Congenital Heart Disease - A Primer
At the end of this session, the participant will be able to:
-Understand the comprehensive transthoracic echocardiographic approach to the evaluation of patients for adult congenital heart disease, including atrial septal defect (ASD), ventricular septal defect (VSD), patent ductus arteriosus (PDA), tetralogy of fallot (TOF) and transposition of the great arteries (TGA).
-Describe the role of the echocardiographic evaluation of patients with adult congenital heart disease in considering interventional and surgical interventions.
-Recognize the indications for and significance of ACHD imaging in pregnancy.
Contemporary Assessment of Pulmonary Hypertension
At the end of this session, the participant will be able to:
-Understand the differences in the ASE and EACVI guidelines for imaging in pulmonary hypertension patients
-Describe the high-risk echocardiographic findings that suggest a poor prognosis in patients with pulmonary hypertension.
-Describe new echocardiographic indices for the evaluation of pulmonary hypertension
EACVI Lecture: Is excessive trabeculation of the left ventricle a disease entity?
At the end of this session, the participant will be able to:
-To explain why the term noncompaction should be discouraged and excessive trabeculation be used instead
-To discuss why presence of excessive trabeculation in adults should not affect clinical management
-To be aware that presence in excessive trabeculation in infants and children may still need special considerations regarding clinical management
Valvular Heart Disease and Trans-Catheter Interventions: Is my Patient a Candidate?
At the end of this session, the participant will be able to:
-Recognize the value of TTE and TEE imaging in TAVI patients.
-Describe the comprehensive transthoracic and transesophageal echocardiographic imaging approach to the evaluation of patients for mitral and tricuspid clip intervention.
-Understand how transesophageal echocardiography can be used to guide mitral and tricuspid clip interventions
Conundrums of the Right-Heart - Clearing the Fog
At the end of this session, the participant will be able to:
-Assess the complex interplay between physiology and morphology in the determination of tricuspid valve function.
-Describe in detail the use of echocardiography in the evaluation of patients who present with tricuspid regurgitation and how to quantitatively assess tricuspid regurgitation
-Recognize the clinical evidence supporting tricuspid clip interventions
Artificial Intelligence: Beyond the Mystique and the Hype
At the end of this session, the participant will be able to:
-Understand the role of artificial intelligence in medical imaging
-Describe artificial intelligence solutions that enable automated measurements and reporting.
-Understand the current and future role of machine/deep learning to practice of echocardiography.
Diastology: Basic to Advanced
At the end of this session, the participant will be able to:
-Describe the role of echocardiography in the assessment of diastolic function, according to ASE and EACVI guidelines
-Understand how to resolve discrepant or indeterminate values in the echocardiographic assessment of diastolic function
Stress Echo: GWTG and Do It Right!
At the end of this session, the participant will be able to:
-Describe role of stress echocardiography in the assessment of the dyspneic patient.
-Understand how to optimally perform a supine exercise bike study.
-Recognize the emerging role of strain assessment in stress echocardiography.
Multimodality Imaging of Acute Ischemic Syndromes
At the end of this session, the participant will be able to:
-Describe the role of echocardiography the assessment of post-MI complications.
-Recognize the value of multimodality imaging in determining the etiology of MINOCA
-Describe the echocardiographic findings in stress cardiomyopathy and myocarditis
ASE Lecture: Echocardiography: at the crossroads of imaging and intervention.
At the end of this session, the participant will be able to:
-Describe the echocardiographic features used in patient selection for transcatheter mitral and tricuspid valve intervention.
-Recognize applications for patient-specific digital and physical modeling.
-Recall the summary points of the new ASE training guidelines for interventional echocardiography.
Trainee How-To: Seeking Opportunities Beyond our Borders
At the end of this session, the participant will be able to:
-Understand the opportunities for advanced echocardiography and research training
-Discuss mechanisms and approaches to achieving competence in advanced echocardiographic techniques
Sonographer Forum: Ergonomics, Workflow, and How to make this Image better?
At the end of this session, the participant will be able to:
-Recognize echocardiographic findings in endocarditis.
-Describe practical and advanced echocardiographic techniques to optimize imaging
-Understand ergonomic and workflow approaches to facilitating echocardiographic studies.
Multidisciplinary Approach to Critical Care Echo
At the end of this session, the participant will be able to:
-Review the role of point of care ultrasound in the hemodynamic assessment of the ICU patient.
-Describe role of critical care to assess the acutely dyspneic patient.
-Understand the role of echocardiography in managing the septic patient.
The Nuts & Bolts of Echo Lab Accreditation
At the end of this session, the participant will be able to:
-Discuss how to set up a quality assurance program in your echo lab.
-Understand how to implement improvements for quality assurance
Special Silver Anniversary Session: "Echo in Canada"
At the end of this session, the participant will be able to:
-Describe the evolution of echocardiography in Canada over the past several decades to better understand the current utility of echocardiography.
-Understand how to integrate established and emerging echocardiographic techniques (such as 3D echo, contrast and strain as well as multimodality imaging) in evaluating patients with valvular heart diseases (including post-intervention), non-ischemic heart disease and stroke/embolism.
-Review evolving echocardiographic and information technology advances that will drive the future of cardiac imaging for clinical management, including artificial intelligence, fusion and vortex imaging
Cases across Canada:
At the end of this session, the participant will be able to:
-Learn from interesting echo cases from across Canada as presented by our national and international faculty members.
-Understand the controversies and key learning points from the cases presented.
-Engage in the discussion around these challenging cases using Twitter audience response and live questioning.
Workshops and Learning Labs – General objectives:
Review four clinically important areas in echocardiography (Strain, 3-D, Contrast Echo, POCUS) in smaller group settings including computer interaction or live scanning to enhance learning and enable interactions among participants.
Strain Learning Lab:
At the end of this session, the participant will be able to:
-Understand the practical aspects of performing 2D strain imaging
-Review the specific 2D strain online and offline echo analysis packages.
-Demonstrate in a small group setting how to optimally use the 2D strain analysis in clinical applications such as follow-up of cancer chemotherapy patients and cardiomyopathies.
3-D Learning Lab:
At the end of this session, the participant will be able to:
-Review the specific 3D online and offline echo analysis packages offered on the GE and Philips platforms.
-Demonstrate in a small group setting how to optimally use the 3D cropping methods.
-Demonstrate in a small group setting how to optimally use the LV and mitral valve analysis packages.
POCUS workshop:
At the end of this session, the participant will be able to:
-Understand how POCUS can be used by the cardiologist in day to day practice
-Perform lung ultrasound technique.
-Recognize the training requirements for the optimal use of POCUS.
-Describe the limitations of hand-help and point-of-care ultrasound to ensure its complementary role with a comprehensive echocardiographic exam.
Contrast workshop:
At the end of this session, the participant will be able to:
-Demonstrate in a live and interactive setting how to utilize echo contrast and incorporate the echo contrast in the workflow of a busy echo lab.
-Describe the basic concepts, indications and practical considerations in contrast echocardiography
-Recognize the incremental value of contrast echo.
Thank You to all of our Sponsors
Parvathy Nair |
Alberto Goffi, MD, is a Staff Physician at St. Michael’s Hospital – Unity Health Toronto and Associate Professor at the University of Toronto, Department of Medicine and Interdepartmental Division of Critical Care Medicine (IDCCM). After graduating from the University of Torino (Italy) and completing his internal medicine training in the same city, he moved to Toronto in 2010 for a fellowship in adult critical care medicine. His clinical and academic interests include neurocritical care and point-of-care ultrasound in acute care medicine, with a focus on lung ultrasound and optimal teaching strategies for its competency achievement. He is the co-lead of the IDCCM Critical Care Ultrasound Curriculum and the co-lead of the Toronto Addis Ababa Academic Collaboration (TAAAC) Adult Critical Care Medicine fellowship.
Alberto loves travelling for teaching; he has already taught ultrasound and neurocritical care in five different continents. In 2015, he won the Young Lecturer Award at the ESICM annual meeting. In 2019, he has been selected as the recipient of the Frank S. Rutledge Award of Excellence in Critical Care Teaching. Outside of work, Alberto has a passion for creating logos and drawings digitally; the IDCCM logo is one of his creations. In the past 4 years, he has learned that nothing is more fulfilling (and tiring!) in life than playing with Sofia and Oliver, his two children.
Allan Klein, MD is the Director of the Center for the Diagnosis and Treatment of Pericardial Diseases and a staff cardiologist in the Section of Cardiovascular Imaging, the Robert and Suzanne Tomsich Department of Cardiovascular Medicine, at the Sydell and Arnold Miller Family Heart Vascular and Thoracic Institute. He the medical director of the HVTI Unique Populations Center/Imbrella. He served as Director of CV Imaging Research for 24 years. Dr. Klein is board-certified in internal medicine and cardiovascular medicine. He is a past president of the American Society of Echocardiography and secretary/treasurer of the National Board of Echocardiography. He is also the Course Director for Valve Diseases, Structural Interventions, and Diastology/Imaging Summit—currently his 25 th course. A Canadian by birth, Dr. Klein speaks French and English.
Specialty Interests: Cardiovascular imaging (echocardiography, cardiac MR and computed tomography); pericardial diseases; amyloid; valvular heart disease; atrial fibrillation; and Diastology
Number of Procedures Performed: Dr. Klein reads well over 2000 echocardiograms per year and performs TEE and intraoperative echocardiogram for the interventional structural program. The pericardial center evaluates over 3000 patients per year of which Dr. Klein sees the majority of patients. He is also heads the pericardiocentesis simulation program which trains the cardiology fellows and performs pericardiocentesis.
Education and Training: Dr. Klein received his medical degree from McGill University in Montreal, Quebec after completing an undergraduate degree in microbiology and immunology, graduating with honors. While in medical school, he received several scholarships and graduated in the top 10 percent of his class. Dr. Klein completed his clinical training at Mount Sinai Hospital in Toronto and the Royal Victoria Hospital in Montreal. He completed a Cardiology Residency from the University of Ottawa Heart Institute and a Research Fellowship from the Mayo Clinic in Rochester, Minn. He was appointed to Cleveland Clinic in 1989.
Research, Publications and Speaking: In addition to his scholarships and academic achievements, Dr. Klein won the E.G.D. Murray Prize in Microbiology and Immunology as an undergraduate and has received multiple American Society of Echocardiography Outcomes Research Awards.
Dr. Klein has been course director and workshop leader at numerous medical specialty conferences focused on clinical trials, imaging modalities and clinical protocols, to name a few. He currently serves as Professor of Medicine at the Cleveland Clinic Lerner College of Medicine of Case Western University. Dr. Klein was a member of the Lerner College of Medicine Admissions Committee. He is on the executive board for the Heart, Vascular and Thoracic Institute at the Cleveland Clinic.
He has been the principal investigator for multicenter clinical trials in atrial fibrillation (ACUTE I, ACUTE II, and CLOTS); studies in diastolic function (ADEPT); valvular heart disease (Anorexigens and Valve Disease); and catheter ablation and pulmonary vein flow (ROTEA). He has published key articles in such prestigious journals such as New England Journal of Medicine, Lancet, European Heart Journal, Circulation, and the Journal of the American College of Cardiology. He chaired the Writing Committee for the document entitled “American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with pericardial disease: Endorsed by the Society for Cardiovascular Magnetic Resonance and Society of Cardiovascular Computed Tomography.” He recently published the RHAPSODY trial with Rilonacept in patients with recurrent pericarditis in the New England Journal of Medicine in 2021.
Dr. Klein was honored to serve as President of the American Society of Echocardiography (ASE) from June 2016 to June 2017 and now he is a Past-President. He has served on the Board of Directors of the ASE and has been the Chair of the Industry Relations Committee and Chair of the Guidelines and Standards Committee and ASE Nominations Committee. He will be honored in 2023 as ASE mentor of the year. Dr. Klein is also on the Board as well as Writing Committee for the National Board of Echocardiography and now is Secretary Treasurer. He served on the Board of Advisors of Cardiovascular Credentialing International. He serves as a peer reviewer for more than 15 professional journals and grades abstracts for the American College of Cardiology, the ASE, the American Heart Association, and the European Society of Cardiology. He is often a Guest Editor for JACC, JACC imaging and Circulation imaging journals.
He has been an invited lecturer at many national and international symposia and conferences, speaking on topics related to his specialty interests. Dr. Klein has authored or co-authored more than 400 peer-reviewed articles in professional journals, co-authored 50 chapters in medical textbooks and published 600 abstracts. He is a co-editor of 2 books entitled "Diastology: Clinical Approach to Diastolic Heart Failure." as well as "Clinical Echocardiography Review: A Self-Assessment Tool." Dr. Klein completed a 2nd edition of the "Clinical Echocardiography Review: A Self-Assessment Tool." He has been the director and co-director of the Valve Disease, Structural Interventions and Diastology/ Imaging Summit courses for the last 25 years. He is also section editor on pericardial diseases for ACC.org and Current Cardiology reports.
Leisure Time Activities:
Dr. Klein is an avid sportsman and enjoys playing ice hockey, cycling, spinning, hiking, golfing and playing many sports. He enjoys reading and traveling around the world.
Professional Highlights:
Writing Chair, American Society of Echocardiography Clinical recommendations for Multimodality Cardiovascular Imaging of Patients with Pericardial Disease - 2013
Sole Speaker for the ASE Webinar “ASE Clinical Recommendations for Multimodality -2013
Notification “In the Spotlight” column of the Cleveland Clinic Professional Staff Update - 2014
Invited Visiting Professor at Mount Sinai Hospital for Anandi L. Sharma Visiting Professorship and Simon Dack, MD Memorial Lecture, Heart Failure with Preserved Ejection Fraction with live presentation at www.heart-talks.org - 2015
Section Editor for Pericardial Disease for ACC.org. – 2016-22
Key Note Speaker: “Constrictive Pericarditis in the 21st Century” at the Portuguese Congress of Cardiology - 2016
Elected President of the American Society of Echocardiography - 2017
Key note speaker as president of ASE in Thailand, South Korea, Japan, Scotland, India and Australia - 2018
Guest Co-Editor for Progress in Cardiovascular Disease 2017; 59(4):325-26.
Co-Editor of “Clinical Echocardiography Review: A Self-Assessment Tool.” 2nd edition. Wolters Kluwer – 2017
Presented with the ESC Life Achievement Award from the Working Group on Myocardial and Pericardial Diseases in Belgrade, Serbia
National PI for the IRB protocol entitled “RHAPSODY: PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED WITHDRAWAL STUDY WITH OPEN-LABEL EXTENSION, TO ASSESS THE EFFICACY AND SAFETY OF RILONACEPT TREATMENT IN SUBJECTS WITH RECURRENT PERICARDITIS”
RHAPSODY trial published in NEJM in 2021
Chair- Study on Impact of CardiolRxTM on Recurrent Pericarditis
North American Coordinating and Lead Principal Investigator for RESONANCE Registry
Memberships:
American Society of Echocardiography
American Heart Association
American College of Cardiology
Royal College of Physicians of Canada
Society of Cardiovascular Computed Tomography
European Society of Cardiology
Awards and Honors:
Fellowships: American College of Cardiology, Royal College of Physicians (Canada), American Society of Echocardiography, American Heart Association, European Society of Cardiology
University Scholarship - 1976-1977
E.G.D. Murray Prize in Microbiology and Immunology University Scholar - 1977
J. W. McConnell Award University Scholarship (Phase 1A Medical School) - 1978-1979
J. W. McConnell Award University Scholarship (Phase 1B Medical School) - 1979-1980
University Scholarship - 1981
Canadian Heart Foundation Research Fellowship - 1986-1988
Finalist Canadian Cardiovascular Society Student's Presentation Award - 1988
First Place ASE Outcomes Research Award - 1997-1998
Abstract entitled “Assessment of Cardioversion Using TEE Multicenter Study (ACUTE I): Clinical Outcomes at 8 Weeks” was included in the ACC 2000 Meeting Highlights Session as Late Breaking Trial - 2000
Mentor for the recipients of the Samuel J. Roessler Memorial Scholarship - 1999-2001
Mentor for the recipients of the Am. Society of Echocardiography Fellowship Award - 2000-2001
Publication of “Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation” in the New England Journal of Medicine - 2001
Abstract entitled “Six-month follow up on patients undergoing a TEE-guided cardioversion from Afib: the assessment of cardioversion using TEE (ACUTE) trial” was included in the AHA Scientific Sessions 2001 Highlight and ACCEL Online - 2001
Publication of “Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation” in the New England Journal of Medicine was sited in Journal Watch Cardiology - 2002
Mentor for the nominee of the American Society of Echocardiography Research Finalist Award - 2003
Publication of “Pericarditis” in The Lancet - 2004
Key Note Speaker: “New Advances in Echocardiography in Atrial Fibrillation" at the X World Congress of Echo & Cardiovascular Imaging Conference - 2006
Publication of “The use of enoxaparin compared with unfractionated heparin for short-term antithrombotic therapy in atrial fibrillation patients undergoing transesophageal echocardiography-guided cardioversion: Assessment of Cardioversion Using Transesophageal Echocardiography (ACUTE) II randomized multicentre study” in the European Heart Journal -2006
Study findings of the ACUTE II were highlighted in the Cleveland Clinic Alumni Newsletter - 2007
Study findings of the ACUTE II were highlighted in the Cleveland Clinic Annual Report - 2007
Grand Rounds presentation at Massachusetts General Hospital on "New Advances in Echocardiography in Afib: What's New in the LAA and Pulmonary Veins?" - 2007
Co-Editor of “Diastology: Clinical Approach to Diastolic Heart Failure.” Saunders, Elsevier, Philadelphia - 2008
Mention of the 11th Diastology and New Echo Technologies Summit Featuring Contrast Echo Mini Symposium was cited in the March 2008 Cleveland Clinic OPSA Memo to Staff” 2008
Mentor for the winner of the Laennec Young Clinician Award at the American Heart Association Scientific Sessions - 2008
New England Journal of Medicine book review for "Diastology: Clinical Approach to Diastolic Heart Failure" in the May 7, 2009, issue - 2009
Co-Editor of “Clinical Echocardiography Review: A Self-Assessment Tool.” Lippincott, Williams & Wilkins, Philadelphia - 2011
CVN (Cardiosource Video Network) Interview Regarding the JACC Imaging Editorial Comment "Annular Velocities in Constrictive Pericarditis - Is it Time to Look Beyond the Annulus" -2011
Author Video for JASE regarding “Role of Transesophageal Echocardiography Compared to Computed Tomography in Evaluation of Pulmonary Vein Ablation for Atrial Fibrillation (ROTEA Study)” - 2011
Cleveland Clinic “Today’s Headlines” included a story entitled “Heart Failure Takes Bigger Toll on Men” that was Published on UPI.com (coauthor of abstract) - 2012
Key Note Speaker: “Is Cardiac Imaging the New Stethoscope?” at the Canadian Cardiovascular Society - 2012
Guideline Chair, American Society of Echocardiography Clinical Recommendations for Multimodality Cardiovascular Imaging of Patients with Pericardial Disease - 2013
Sole Speaker for the ASE Webinar “ASE Clinical Recommendations for Multimodality Cardiovascular Imaging of Patients with Pericardial Disease: A Guideline in Review” - 2013
Notification “In the Spotlight” column of the Cleveland Clinic Professional Staff Update announced the recent appointment of Vice President of the ASE. After a one-year term, president-elect and then president - 2014
Invited Visiting Professor at Mount Sinai Hospital for Anandi L. Sharma Visiting Professorship and Simon Dack, MD Memorial Lecture, Heart Failure with Preserved Ejection Fraction with live presentation at www.heart-talks.org - 2015
13th Annual Tajik/Seward Lectureship, Cleveland Clinic HVI National Leadership and Diseases Center and IPU Development - 2015
Section Editor for Pericardial Disease for ACC.org - 2016
Key Note Speaker: “Constrictive Pericarditis in the 21st Century” at the Portuguese Congress of Cardiology - 2016
President of the American Society of Echocardiography – 2016-2017
Notification in the Cleveland Clinic “Weekly Scoop: News from the Chief of Staff” 5 Questions section on providing a one-stop-shop for patients with pericardial disease - 2017
Physician’s Weekly article, “Key Concepts in Managing Complicated Pericarditis” - 2017
Guest Co-Editor for Progress in Cardiovascular Disease 2017;59(4):325-26
Co-Editor of “Clinical Echocardiography Review: A Self-Assessment Tool.” 2nd Edition. Wolters Kluwer - 2017
Presented with the ESC Life Achievement Award from the Working Group on Myocardial and Pericardial Diseases in Belgrade, Serbia -2018
Presented the 29th Edler lecture, “Dermatology of the Heart: Tales from the Pericardial Sac,” at the American Society of Echocardiography Scientific Sessions-2018
National PI for the IRB protocol entitled “RHAPSODY: PHASE 3, DOUBLE-BLIND, 2018
PLACEBO-CONTROLLED, RANDOMIZED WITHDRAWAL STUDY WITH OPEN-
LABEL EXTENSION, TO ASSESS THE EFFICACY AND SAFETY OF RILONACEPT
TREATMENT IN SUBJECTS WITH RECURRENT PERICARDITIS -2018
Listed as “HVI Physicians Ranked in the Top 100,000 Scientists (Top 1%) in the World.” This was noted in the September Cleveland Clinic Professional Staff Update- 2019
ASE 2023 mentorship award
Innovations and Patents:
Dr. Klein has pioneered the use of transesophageal-guided cardioversion in patients with atrial fibrillation in his landmark paper in the New England Journal of Medicine published in 2001 and the European Heart Journal in 2006. He directs one of the largest pericardial center in the world which evaluates complex patients with different pericardial diseases. He led the RHAPSODY Trial for recurrent pericarditis and published in New England Journal of Medicine in 2021
Additional Training: Leading in Health Care Business Program at the CCF, Leadership Training with the ASE (Tecker International), Cleveland Clinic HVTI Personal Healthcare Leadership Development Series
Dr. Amélie Paquin is a fellow in Advanced Echocardiography and Women’s Cardiovascular Health at the University of Ottawa Heart Institute. She completed her cardiology training and a master’s degree in clinical Epidemiology at Laval University. She is also currently undergoing doctoral studies in collaboration with Laval University, studying the sex-specific impact of cardiometabolic risk factors on myocardial remodeling. She is supported by scholarships from the Canadian Institutes of Health Research, Fonds de recherche du Québec en santé, Association des cardiologues du Québec, and Laval University McLaughlin Dean’s Scholarship.
Dr. Anna Woo received her MD degree at McGill University and she trained in Cardiology and Echocardiography at the University of Toronto. She completed her Master of Science degree in Epidemiology at the Harvard School of Public Health.
Dr. Woo is a staff cardiologist based at the Toronto General Hospital (TGH), where she attends in the Hypertrophic Cardiomyopathy (HCM) Clinic. In addition, she is the Director of the Echocardiography Laboratory at the University Health Network (Toronto General and Toronto Western Hospitals).
Dr. Woo’s research and academic interests have mainly focused on HCM and on advanced echo techniques. She has contributed to a number of national and international guidelines, including the 2011 and 2022 versions of the American Society of Echocardiography Guidelines for multimodality imaging in HCM. Dr. Woo is on the Board of Directors of the HCM Society (HCMS).
Dr. Aws Almufleh is a cardiologist specializing in echocardiography and advanced heart failure. He is the Physician Lead of the Heart Function Clinic and holds academic appointment at the rank of Assistant Professor of Medicine at Queen’s University. He received his medical degree with First Class Honors from King Saud University, Riyadh, Saudi Arabia in 2012. He then completed a Master of Public Health (MPH) at the University of Miami focusing on epidemiology and clinical research. He did internal medicine residency at McGill University where he served as the Chief Medical Resident. Following cardiology fellowship training at the University of Ottawa Heart Institute (2016-2019), Dr. Almufleh completed an advanced heart failure and cardiac transplantation fellowship at the Brigham and Women’s Hospital/Harvard Medical School (2019-2020) and earned the Pierce Fellow Award for Scholarship in Cardiomyopathy in recognition of his clinical and research achievements. Dr. Almufleh also completed an advanced echocardiography fellowship at Vancouver General Hospital/University of British Columbia (2020-2021). Concurrently, he pursued research training through the Global Clinical Scholars Research Training (GCSRT) program at Harvard Medical School with emphasis on advanced quantitative research methodology and study design.
Dr. Almufleh has a keen interest in medical education and echocardiography. He is the Echocardiography rotation director for cardiology fellows and non-cardiology learners at Queen’s University. He moderates a weekly echocardiography teaching round where faculty goes over interesting echocardiograms with cardiology fellows and sonographers. He is a faculty member of the Queen’s Point of Care Ultrasound (POCUS) fellowship training program. Furthermore, he is serving a two-year term as a member-at-large in the Canadian Society of Echocardiography Board of Directors. As for research pursuit, Dr. Almufleh, under the mentorship of Dr. Parvathy Nair from the University of British Columbia, is the lead author of a medical education project aimed at optimizing echocardiography competency training during cardiology fellowship which earned the Canadian Cardiovascular Ultrasound Research Excellence Award for Technology & Education – $50,000 CREATE Grant. He is also a co-investigator in the echocardiography online quality assessment and direct feedback modules project led by Drs. Robin Ducas and Che-Ming Chow. Dr. Almufleh has published over 25 peer-reviewed articles and was a co-investigator of the large-scale randomized controlled trial comparing Milrinone with Dobutamine in the Treatment of Cardiogenic Shock; published in the New England Journal of Medicine in August 2021.
Carly Burry is a cardiac sonographer at the Colchester East Hants Health Authority in Truro, Nova Scotia. After completing her Bachelor of Kinesiology, she completed her Cardiac Sonography program at Mohawk College and began her career as a Sonographer.
MDCM MSc FRCPC FCCS FASE DBIM CPC(HC) Professor in Medicine, University of Toronto Director, Echocardiography Lab Staff Cardiologist, St. Michael's Hospital
Dr. Chi-Ming Chow is an attending staff cardiologist at St. Michael’s Hospital. He is a full professor in the Department of Medicine, University of Toronto. He has an undergraduate degree in computer science from Brown University, USA. He completed his Doctor of Medicine (1990) at McGill University (Montréal, Québec) and a Masters of Science in Epidemiology at McGill University (1997). He completed his training in Family Medicine, Internal Medicine and Cardiology at McGill University. He then pursued his clinical and research echocardiography fellowship at Massachusetts General Hospital, Harvard University before joining the Division of Cardiology at St. Michael’s Hospital in 2001.
Clinically he specializes in non-invasive cardiac imaging, in particular echocardiography and stress echocardiography. He is the Director of the Echocardiography Laboratory at St. Michael’s Hospital. Currently, he a past president of the Canadian Society of Echo (CSE) and the president of the Chinese Canadian Medical Society (CCMS).
Credentials/Training:
Undergraduate medicine, McGill University, 1998-2001
Internal Medicine, McGill University, 1995-1998
Cardiology, McGill University, 1998-2001
Echocardiography Fellowship, McGill University, 2001-2002
Cardiovascular MRI Fellowship, National Institutes of Health, 2002-2004
Current Positions:
Staff Cardiologist, University of Ottawa Heart Institute, 2022-present
Professor, Faculty of Medicine, University of Ottawa
Co-Director, Cardiac MRI, University of Ottawa Heart Institute
Director, Rare Cardiac Conditions Centre, University of Ottawa Heart Institute
Board member, Canadian Cardiac Oncology Network
Past Positions/Appointments:
Professor and Cardiologist, University of Alberta, 2004-2022
Past Director, Residency Training Adult Cardiology, University of Alberta, 2009-2017
Associate Director and Competence Committee Chair, Residency Training Adult Cardiology, University of Alberta, 2021-2022
Clinical Director, Edmonton Cardio-Oncology program
Past President, Canadian Society for Cardiovascular Magnetic Resonance
Clinical and Academic Interests:
Prevention and treatment of chemotherapy related cardiotoxicity
Advanced cardiac imaging (MRI and echo)
Heart Failure/Amyloidosis/Sarcoidosis
Post-COVID syndrome
Medical Education
Recreational Activities:
Ice Hockey
Cross-country skiing
Cycling
Vice-President, Canadian Society of Echocardiography: Professor of Medicine, McGill University; Director of Echocardiography and Non-Invasive Cardiology, Jewish General Hospital,
Assistant Professor of Medicine, McGill University / Professeur adjoint de médecine, Université McGill
Director, Echocardiography & Non-invasive Cardiology / Directeur, échocardiographie et cardiologie non-effractive
McGill University Health Center (MUHC) / Centre universitaire de santé McGill (CUSM)
Royal Victoria Hospital / Hôpital Royal Victoria
Dr. Kareem Morant is an Echocardiographer and Assistant Professor at North York General Hospital (NYGH) in Toronto, ON. After completing Cardiology training at University of Toronto, he completed his Advanced Echocardiography Fellowship at Mayo Clinic in Rochester MN.
Currently, he is the Director of the Heart Function Clinic at NYGH and is a member of the Transcatheter Heart Valve Team at Sunnybrook Hospital in Toronto.
Dr. Morant’s areas of interest include Imaging, Valvular Heart Disease, Heart Failure and A-TTR Cardiomyopathy, where he has a particular interest in how it effects the Canadian Black population. Furthermore, he enjoys teaching and mentoring trainees of all levels, and is passionate about advocating for improving diversity and inclusivity in medicine.
Lawrence Lau, MD, is a cardiologist at the University of Ottawa Heart Institute and an assistant professor in the Faculty of Medicine at the University of Ottawa.
Dr. Lau graduated from the University of Manitoba, receiving a Bachelor of Science degree with distinction in 2011. He earned his medical degree in 2015 followed by a residency in internal medicine in 2018, also at the University of Manitoba. He then completed a residency in cardiology at the UOHI in 2021, followed by a fellowship in echocardiography at the UOHI in 2022.
Dr. Lau’s research interests include infective endocarditis, echocardiography, and valve disease.
Marie-Josée Blais is Chief Cardiac Sonographer at the Jewish General Hospital, a McGill University affiliated hospital. She graduated as a medical imaging technologist in 1991 and obtained her ARDMS certification in adult and pediatric echocardiography in 1995. She is currently an inspector of the Order of Technologists of Quebec (OTIMRO). She served on the CSE Board of Directors and has lectured at numerous national and international meetings, including the ASE and CSE annual meetings.
Her interests include standardization in echocardiography, quality improvement and contrast imaging
Dr. Fine is a heart failure cardiologist and echocardiologist in Calgary (Alberta Canada). He is an Associate Clinical Professor of Cardiac Sciences, Medicine and Community Health Sciences at the Cumming School of Medicine, University of Calgary. He is the Clinical Director of the Libin Cardiovascular Institute. He is director of Clinical and Research/Core Echocardiography Laboratories, and co-lead of Heart Failure research program. Dr. Fine has a clinical and research interest in heart failure and infiltrative cardiomyopathies, particularly cardiac amyloidosis and Anderson-Fabry disease, and is Co-Director of the Amyloidosis Program of Calgary and Cardiac Amyloidosis Clinic. He is the co-principal investigator for the Canadian Registry for Amyloidosis Research.
Directeur de la recherche en cardiologie | Head of Cardiology Research
Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval
Professeur titulaire, Département de médecine | Professor, Department of Medicine
Chaire de recherche du Canada sur les maladies valvulaires cardiaques
Canada Research Chair in Valvular Heart Diseases
Université Laval
Dr. Sarah Blissett is an Assistant Professor of Medicine, Co-Program Director of Adult Cardiology Subspecialty Training Program, and a Centre Researcher at the Centre for Education Research and Innovation (CERI)
Following completion of medical school at the University of Toronto, Internal Medicine at University of Toronto and Cardiology at Western University, she completed fellowships in Integrated Cardiac Imaging (Echocardiography and Cardiac MRI, McGill University, Montreal) and Adult Congenital Heart Disease (UCSF, San Francisco). Concurrent to these fellowships, she obtained a Master of Health Professions Education from Maastricht University.
Dr. Blissett's clinical work focuses on cardiac imaging, Adult Congenital Heart Disease and Cardio-Obstetrics. Her academic interests are focused on improving education in Cardiology, particularly in optimizing learning in workplace learning environments
.
President, Canadian Society of Echocardiography: Professor of Medicine, Dalhousie University; QE II Health Sciences Centre
Dr. Mulvagh is Professor of Medicine at Dalhousie University, Halifax, Nova Scotia Canada, Professor Emeritus at Mayo Clinic, Rochester, MN, USA, and President of the Canadian Society of Echocardiography.
Dr. Mulvagh is a clinical cardiologist, echocardiographer, and clinician investigator for multiple Federal (CIHR-Canadian Institute of Health Research) and Foundation (Heart and Stroke Canada; Dalhousie University) funded research projects in Canada and USA focused on women and heart disease, contrast echocardiography, and POCUS. She is Co-Director of the Women’s Heart Health Clinic at the Maritime Heart Center in Halifax, NS, Chair of the Nova Scotia Provincial Board of Directors for Heart & Stroke Canada, Immediate Past-Chair of Canadian Women's Heart Health Alliance, Knowledge Translation and Mobilization Working Group, immediate-past Chair of American Society of Echocardiography (ASE) Scientific Sessions Chair, current member of National Board of Echocardiography (NBE) Critical Care Echocardiography Exam Writing Committee, and NBE and ASE Certification Committees, past member of ASE Board of Directors and current member of International Contrast Ultrasound Society Board of Directors. She has chaired numerous echocardiographic guidelines imaging task forces and committees, including Guidelines on Ultrasound Enhancing Agents and two updates. She has over 150 peer reviewed publications, and is on the editorial boards of Canadian Journal of Cardiology, Journal of the American Society of Echocardiography, and Journal of the American College of Cardiology.
Dr. Mulvagh received her medical degree, magna cum laude, from University of Ottawa, Canada, interned at Dalhousie University, then completed her residency at Boston University, and cardiology fellowship at Baylor College of Medicine in Houston, TX. There, she consulted for Universities Space Research Associates (USRA) at NASA, Johnson Space Center, monitoring cardiac responses during spacewalks from Mission Control, training astronauts to do echocardiograms during spaceflight and developing countermeasures to microgravity. She continues to intermittently serve on NASA peer review committees.
Dr. Little holds the John S. Dunn Chair in Clinical Cardiovascular Research and Education, and is the Houston Methodist System Director for Structural Heart, and the program director for the Cardiovascular Disease Fellowship program at Houston Methodist Hospital. A longtime ASE member, Dr. Little previously chaired the ASE Guidelines and Standards Committee as well as the Structural Heart Disease Industry Task Force. He served on ASE’s Board of Directors from 2015-2018 before being elected to the Presidential Ladder in 2020.
He is a Professor of Medicine at Weill Cornell Medicine, and adjunct professor of Bioengineering at Rice University. He received his medical degree from McMaster University and completed post graduate training in internal medicine and cardiology at Western University. He completed research fellowships in echocardiography at the University of Ottawa Heart Institute and at Baylor College of Medicine, Houston, Texas.
His research activities have focused on novel use of 3-D echocardiography for the quantification of native and prosthetic valve dysfunction as well as imaging guidance for percutaneous structural heart interventions. Research funding provided by the American Heart Association, and the National Sciences Foundation.
Steven Promislow graduated from medical school at the University of Manitoba in 2010 and completed his residency training in internal medicine at the University of Manitoba in 2013. He went on to complete his cardiology residency in 2016 at the University of Ottawa Heart Institute, followed by fellowships in both adult echocardiography and cardiac CT/nuclear cardiology. He subsequently joined the Division of Cardiology at the University of Ottawa Heart Institute before returning to Winnipeg in 2021 to join WRHA Cardiac Sciences and the Section of Cardiology within the Department of Medicine at the University of Manitoba.
His academic interests lie in multimodality cardiac imaging and their application in clinical practice. He is also actively involved in education at both the undergraduate and postgraduate levels.
Director of Echo Lab, VGH and UBC
Director of VGH-UBC Artificial Intelligence Echo Core Lab
Professor of Medicine, Division of Cardiology
Associate Head Research, Department of Medicine University of British Columbia